These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 508325)

  • 21. Nicotinamide coenzymes in heart and coronary blood during myocardial infarction.
    Núñez R; Calva E; Briones E; López-Soriano F
    Am J Physiol; 1974 Jan; 226(1):73-6. PubMed ID: 4149173
    [No Abstract]   [Full Text] [Related]  

  • 22. Myocardial ischemia (second of three parts).
    Hillis LD; Braunwald E
    N Engl J Med; 1977 May; 296(18):1034-41. PubMed ID: 321964
    [No Abstract]   [Full Text] [Related]  

  • 23. Chinese patent medicine Xin-Ke-Shu inhibits Ca
    Yang Y; Jia H; Yu M; Zhou C; Sun L; Zhao Y; Zhang H; Zou Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1079():85-94. PubMed ID: 29454926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myocardial distribution of C-14 lidocaine and C-14 propafenone in relation to regional myocardial blood flow in a model of chronic-phase myocardial infarct].
    Naccarella F; Agarwal JB; Weintraub WS; Bracchetti D; Ambrosioni E; Helfant RH
    Cardiologia; 1988 May; 33(5):453-8. PubMed ID: 3167892
    [No Abstract]   [Full Text] [Related]  

  • 25. Occurrence of N-acylethanolamine phospholipids in fish brain and spinal cord.
    Natarajan V; Schmid PC; Reddy PV; Zuzarte-Augustin ML; Schmid HH
    Biochim Biophys Acta; 1985 Jul; 835(3):426-33. PubMed ID: 4016139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac sympathetic nerve function assessed by [131I]metaiodobenzylguanidine after ischemia and reperfusion in anesthetized dogs.
    Takatsu H; Duncker CM; Arai M; Becker LC
    J Nucl Cardiol; 1997; 4(1 Pt 1):35-41. PubMed ID: 9138838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of metabolic shift in post-infarct-remodelled hearts: possible novel therapeutic approach.
    Tanno M; Kuno A
    Cardiovasc Res; 2013 Feb; 97(2):195-6. PubMed ID: 23234681
    [No Abstract]   [Full Text] [Related]  

  • 28. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
    Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
    J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of lipids in cardiac muscle hypertrophied by severe hypoxia: the effects of diphosphothiamine and an antagonist of vitamin B1.
    Alberghina M; Palermo F
    Ital J Biochem; 1974; 23(2):96-120. PubMed ID: 4414653
    [No Abstract]   [Full Text] [Related]  

  • 30. Myocardial lipid metabolism in ischemia and infarction.
    Bruce TA; Myers JT
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():773-80. PubMed ID: 4806678
    [No Abstract]   [Full Text] [Related]  

  • 31. Fractional composition and metabolism of proteins, and levels of polynucleotides, in canine heart in experimental myocardial infarction.
    Fetisova TV; Smirnova IP
    Cor Vasa; 1975; 17(4):278-84. PubMed ID: 1212873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reperfused-viable and reperfused-infarcted myocardium: differentiation with in vivo P-31 MR spectroscopy.
    Rehr RB; Tatum JL; Hirsch JI; Quint R; Clarke G
    Radiology; 1989 Jul; 172(1):53-8. PubMed ID: 2740521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Manifestation of the oxygen paradox during perfusion of the ischemic myocardium and its prevention by chlorpromazine and protease inhibition].
    Slezák J; Tribulová N; Gabauer I; Ziegelhöffer A; Styk J
    Bratisl Lek Listy; 1984 Mar; 81(3):266-81. PubMed ID: 6200190
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of nitroglycerine administered by intravenous infusion upon coronary flow and cardiac metabolism. Continuous study during experimental myocardial infarction].
    Cahn J; Angignard J; Pawelec C; Lebeau M; Weber S
    Nouv Presse Med; 1979 Jan; 8(4):239-49. PubMed ID: 122014
    [No Abstract]   [Full Text] [Related]  

  • 35. [Characteristics of metabolism of the myocardium].
    Yamamura Y
    Nihon Ishikai Zasshi; 1970 Sep; 64(6):723-34. PubMed ID: 5466631
    [No Abstract]   [Full Text] [Related]  

  • 36. The mass spectrometric measurement of intramural carbon dioxide tension to assess the efficacy of interventions to limit myocardial ischemic injury.
    Hillis LD; Khuri S; Braunwald E; Kloner RA; Tow D; Barsamian E; Maroko PR
    Trans Assoc Am Physicians; 1978; 91():259-67. PubMed ID: 754393
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolic changes in infarcted and non-infarcted myocardium during the postinfarction period.
    Gudbjarnason S; Ravens KG; Mathes P
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():439-46. PubMed ID: 4681474
    [No Abstract]   [Full Text] [Related]  

  • 38. The evolution of myocardial infarction: physiological basis for clinical intervention.
    Guyton RA; Daggett WM
    Int Rev Physiol; 1976; 9():305-39. PubMed ID: 789283
    [No Abstract]   [Full Text] [Related]  

  • 39. Heat clearance and heat production studies in acute experimental coronary occlusion.
    Grayson J; Robertson M; Scott C
    Cardiovasc Res; 1973 Mar; 7(2):220-5. PubMed ID: 4694106
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical changes in non-infarcted heart muscle following myocardial infarction.
    Gudbjarnason S; Mathes P
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():581-9. PubMed ID: 4806989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.